BioVie Inc. announced it will present new biomarker data from its Phase 2 ADDRESS-LC trial of bezisterim, a drug targeting Long COVID symptoms, at the 4th Long COVID International Conference in France on November 13, 2026. The trial showed bezisterim improved fatigue, post-exertional malaise, and cognition in patients with severe symptoms. This data supports bezisterim's potential as a treatment for Long COVID, a condition affecting millions with no FDA-approved therapies. The presentation marks a significant step toward further clinical development of the drug.
BioVie and its bezisterim drug for Long COVID provide context for the health sector's market snapshot on Pluang as of Nov 02, 2026 20:02 WIB. Among 150 health-sector US stocks, 87 rose and 43 fell today. Heron Therapeutics Inc (HRTX) gained 4.43% to USD 0.29 with a typical hold time of 38 days, contrasting with MiniMed Group Inc. (MMED) which dropped 2.95% to USD 17.74 and a shorter hold time of 13 days, while ClearPoint Neuro Inc (CLPT) rose 3.84% to USD 11.10 with a 12-day hold time.
Maurizio Mian, known as the pioneer of influencer culture, has launched a new micro-drama series called 'The Experiment.' The show features popular social media personalities living in luxury while exploring whether happiness can be measured and incr...
The global wealth management software market, valued at $6.28 billion in 2025, is projected to reach $18.77 billion by 2033, growing at a 14.7% CAGR. Growth is fueled by rising adoption of AI, automation, and digital advisory tools that enhance workf...
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
